Previous Close | 2.8500 |
Open | 2.8700 |
Bid | 2.8600 x 800 |
Ask | 2.8700 x 800 |
Day's Range | 2.8300 - 2.8700 |
52 Week Range | 1.7000 - 3.5800 |
Volume | |
Avg. Volume | 334,395 |
Market Cap | 267.738M |
Beta (5Y Monthly) | 1.54 |
PE Ratio (TTM) | 57.10 |
EPS (TTM) | 0.0500 |
Earnings Date | Apr 25, 2023 - May 01, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 8.17 |
Key Insights Given the large stake in the stock by institutions, Accuray's stock price might be vulnerable to their...
Investors continue to be optimistic about Accuray (ARAY) owing to strong demand for its products.
Healthcare costs in America and the world are set to rise in the foreseeable future. All thanks to an aging population, and the expectation that healthcare companies will be able to cure more of our diseases. The companies that can break into new markets by curing new diseases are set to profit the most from the coming healthcare boom. All of which is great news for healthcare stocks. In fact, companies like CRISPR Therapeutics (NASDAQ:CRSP) need to show that their new technology is safe, effect